Type 1 Diabetes Reversed by Integrating Mesenchymal Stem Cells.

MSCs and HCELL molecules track down islet cells and reverse inflammation.

According to a recently published study from the Brigham and Woman’s Hospital, mesenchymal stem cells [MSCs] have the ability to reverse type I diabetes by suppressing the auto-immune attack of islet cells.  Although the MSCs cannot be directly injected into the pancreas, the researchers utilized the surface adhesion molecule HCELL to hone the stem cells in on the inflamed islets, allowing them to normalize blood sugar levels without the use of insulin. Continue reading

Type 1 Diabetes Treatment Utilizes Stem Cells to Regenerate Pancreatic Beta Cells

Stem cells have been differentiated into pancreatic beta cells, providing a potential treatment for Type 1 Diabetes.

Researchers from the Gladstone Institutes have developed a potential treatment for Type 1 diabetes by differentiating stem cells into insulin-producing pancreatic beta cells.  These new cells, when transplanted into animal models, lowered abnormally high glucose levels down to a more healthy level in just one week. Continue reading